SHSE:688621 (China)
Â
Class A
Â¥
43.04
(+7.63%)
Jul 5
New Key Statistics Module, Z-Score and F-Score
SHSE:688621 Key Ratios
Market Cap ¥ M | 4,478.88 |
Enterprise Value ¥ M | 4,325.76 |
P/E(ttm) | 23.02 |
PE Ratio without NRI | 17.85 |
Forward PE Ratio | -- |
Price/Book | 4.75 |
Price/Sales | 5.07 |
Price/Free Cash Flow | 39.45 |
Price/Owner Earnings | 32.75 |
Payout Ratio % | 0.25 |
Revenue (TTM) ¥ M | 951.00 |
EPS (TTM) ¥ | 1.87 |
Beneish M-Score | -2.35 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 41.80 |
y-y EBITDA Growth Rate % | 18.40 |
EV-to-EBIT | 18.87 |
EV-to-EBITDA | 18.87 |
PEG | 0.43 |
Shares Outstanding M | 112.00 |
Net Margin (%) | 22.02 |
Operating Margin % | 29.84 |
Pre-tax Margin (%) | 22.62 |
Quick Ratio | 1.77 |
Current Ratio | 1.79 |
ROA % (ttm) | 12.09 |
ROE % (ttm) | 21.02 |
ROIC % (ttm) | 25.83 |
Dividend Yield % | -- |
Altman Z-Score | 4.35 |
SHSE:688621 Number of Guru Trades
SHSE:688621 Volume of Guru Trades
Gurus Latest Trades with SHSE:688621
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:688621 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Beijing Sun-Novo Pharmaceutical Research Co Ltd Insider Transactions
No Available Data